Company Filing History:
1 out of 1,309 
1 out of 2,597 
Years Active: 2011
Title: Innovations in ALS Treatment: The Work of Inventor Karen Wallace
Introduction
Karen Wallace, based in Newton Square, PA, is a notable inventor recognized for her groundbreaking contributions to the field of medical research. With a focus on developing novel therapies, she has significantly influenced the understanding and treatment of certain degenerative disorders, particularly amyotrophic lateral sclerosis (ALS).
Latest Patents
Karen Wallace holds a patent titled "Antagonist antibodies against GDF-8 and uses in treatment of ALS and other GDF-8 associated disorders." This patent showcases innovative molecules related to growth and differentiation factor-8 (GDF-8). Her work specifically includes mouse and humanized antibodies that inhibit GDF-8 activity and signaling both in vitro and in vivo. The patent further outlines methods for diagnosing, treating, and monitoring muscle, bone, and insulin metabolism disorders, with a keen emphasis on ALS. Additionally, it discusses pharmaceutical compositions leveraging these antibodies and related components for therapeutic interventions.
Career Highlights
Throughout her career, Karen Wallace has been associated with prominent organizations, including Wyeth and the University of Pennsylvania. Her experience in these institutions has contributed to her expertise and advancements in the medical field, particularly in developing treatments for complex disorders linked to GDF-8.
Collaborations
Karen has worked alongside esteemed colleagues such as Frank S Walsh and Margaret Maria Zaleska. These collaborations have been pivotal in enhancing the research output and clinical applications of her innovative findings, allowing for a multidisciplinary approach to tackling critical health challenges.
Conclusion
Karen Wallace exemplifies the spirit of innovation in the medical research landscape. Her patented work on antagonistic antibodies against GDF-8 represents a significant stride toward effective therapies for ALS and related disorders. Through her career and collaborations, she continues to inspire future developments in the realm of healthcare innovations.